CBD

Medical Marijuana in the treatment of Multiple Sclerosis.
Post Reply
User avatar
Petr75
Family Elder
Posts: 1152
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic

CBD

Post by Petr75 » Sun Dec 06, 2020 7:42 am

2020 Nov 9
Department of Anatomy, Dongguk University College of Medicine, Gyeongju 38066, Republic of Korea
Emerging potential of cannabidiol in reversing proteinopathies
https://pubmed.ncbi.nlm.nih.gov/33181336/

Abstract

The aberrant accumulation of disease-specific protein aggregates accompanying cognitive decline is a pathological hallmark of age-associated neurological disorders, also termed as proteinopathies, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and multiple sclerosis. Along with oxidative stress and neuroinflammation, disruption in protein homeostasis (proteostasis), a network that constitutes protein surveillance system, plays a pivotal role in the pathobiology of these dementia disorders. Cannabidiol (CBD), a non-psychotropic phytocannabinoid of Cannabis sativa, is known for its pleiotropic neuropharmacological effects on the central nervous system, including the ability to abate oxidative stress, neuroinflammation, and protein misfolding. Over the past years, compelling evidence has documented disease-modifying role of CBD in various preclinical and clinical models of neurological disorders, suggesting the potential therapeutic implications of CBD in these disorders. Because of its putative role in the proteostasis network in particular, CBD could be a potent modulator for reversing not only age-associated neurodegeneration but also other protein misfolding disorders. However, the current understanding is insufficient to underpin this proposition. In this review, we discuss the potentiality of CBD as a pharmacological modulator of the proteostasis network, highlighting its neuroprotective and aggregates clearing roles in the neurodegenerative disorders. We anticipate that the current effort will advance our knowledge on the implication of CBD in proteostasis network, opening up a new therapeutic window for aging proteinopathies.

User avatar
NHE
Volunteer Moderator
Posts: 5612
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: CBD

Post by NHE » Sun Dec 06, 2020 9:57 pm

Petr75 wrote:
Sun Dec 06, 2020 7:42 am
2020 Nov 9
Department of Anatomy, Dongguk University College of Medicine, Gyeongju 38066, Republic of Korea
Emerging potential of cannabidiol in reversing proteinopathies
https://pubmed.ncbi.nlm.nih.gov/33181336/

Free full text. https://www.sciencedirect.com/science/a ... via%3Dihub

Post Reply

Return to “Medical Marijuana”